{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:59:16Z","timestamp":1792875556529,"version":"4.5.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.ico.0000154391.28254.1d","type":"journal-article","created":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T10:11:35Z","timestamp":1121249495000},"page":"742-744","source":"Crossref","is-referenced-by-count":53,"title":["Therapy of Progressive Rheumatoid Arthritis-Associated Corneal Ulceration With Infliximab"],"prefix":"10.1097","volume":"24","author":[{"given":"Justus W","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C","family":"Pflugfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-17-20210204","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis; effects of systemic immunosuppression.","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"R3-17-20210204","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/rheumatology\/38.12.1245","article-title":"Peripheral ulcerative keratitis corneal melt and rheumatoid arthritis: a case series.","volume":"38","author":"Squirrell","year":"1999","journal-title":"Rheumatology"},{"key":"R4-17-20210204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0896-1549(02)00036-6","article-title":"Immunosuppression in uveitis.","volume":"15","author":"Djalilian","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"R5-17-20210204","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000048164","article-title":"Treatment of rheumatoid arthritis by TNF-blocking agents.","volume":"127","author":"Graninger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"R6-17-20210204","doi-asserted-by":"crossref","first-page":"ii67","DOI":"10.1136\/ard.61.suppl_2.ii67","article-title":"Infliximab treatment for rheumatologic disease: clinical and radiological efficacy.","volume":"61","author":"St Clair","year":"2002","journal-title":"Ann Rheumatol Dis"},{"key":"R7-17-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.85.2.147","article-title":"Tear film MMP accumulation and corneal disease.","volume":"85","author":"Smith","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R8-17-20210204","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1515\/BC.2003.097","article-title":"Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.","volume":"384","author":"Bode","year":"2003","journal-title":"Biol Chem"},{"key":"R9-17-20210204","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/exer.2001.1054","article-title":"Regulation of MMP-9 in human corneal epithelial cells.","volume":"73","author":"Li","year":"2001","journal-title":"Exp Eye Res"},{"key":"R10-17-20210204","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1167\/iovs.02-0874","article-title":"Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells.","volume":"44","author":"Li","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-17-20210204","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1074\/jbc.M107611200","article-title":"Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration.","volume":"277","author":"Mohan","year":"2002","journal-title":"J Biol Chem"},{"key":"R12-17-20210204","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.ICL.0000092064.05514.04","article-title":"Treatment of sterile corneal\/scleral ulceration with etanercept.","volume":"30","author":"Hernandez-Illas","year":"2004","journal-title":"Eye Contact Lens"},{"key":"R13-17-20210204","first-page":"437","article-title":"Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor.","volume":"160","author":"Fox","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R14-17-20210204","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ico.0000154391.28254.1d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:51:16Z","timestamp":1785855076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200508000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ico.0000154391.28254.1d","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}